http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1004138&ProfileId=051205&sourceType=1NEW YORK, NY -- (Marketwired) -- 04/05/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
China Housing & Land Development, Inc. (NASDAQ: CHLN) shares gained 24.70 percent on volume of 2.0 million shares traded Wednesday to close at $2.07 a share. The company reported total revenues for the fourth quarter of 2012 were $61.5 million, an increase 112.8 percent when compared to the previous quarter.
Find out more about China Housing & Land including full access to the free equity report at: www.BedfordReport.com/CHLN
Magnum Hunter Resources Corp. (NYSE: MHR) shares spiked 3.15 percent on more than three times the average daily volume Wednesday to close at $3.93 a share. The company announced an agreement to sell its Eagle Ford Shale properties in Gonzales and Lavaca Counties of South Texas to Penn Virginia Corp. for $401 million.
Find out more about Magnum Hunter Resources including full access to the free equity report at: www.BedfordReport.com/MHR
Microvision, Inc. (NASDAQ: MVIS) shares soared 58.12 percent on volume of over 3.1 million shares traded Wednesday to close at $2.53 a share. The company announced that it has reached a development agreement with a prominent electronics company. MicroVision is expected to receive $4.6 million in development fees over the next 13 months.
Find out more about Microvision including full access to the free equity report at: www.BedfordReport.com/MVIS
Novogen Limited (NASDAQ: NVGN) shares unexpectedly soared 40.21 percent on volume of 874,649 shares traded Tuesday to close at $6.05 a share. The company in February reported positive results from an important study of its lead experimental drug, CS-6. CS-6 has "shown potent anti-cancer activity against cancer cells".
Find out more about Novogen including full access to the free equity report at: www.BedfordReport.com/NVGN
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.
Contact Information:
Equity News Circuit
Email Contact